Invitation to the presentation of IRLAB´s Interim report January – September 2021

November 5, 2021

IRLAB Therapeutics AB (publ) will publish the interim report for the period January – September 2021 on Wednesday 10 November 2021 at 07:45 CET. A conference call will be held the same day starting at 10:30 CET, where CEO Nicholas Waters and CFO Viktor Siewertz will present the report. The presentation will be held in Swedish and will be followed by a Q&A session.

IRLAB Therapeutics AB (publ) will publish the interim report for the period January – September 2021 on Wednesday 10 November 2021 at 07:45 CET. A conference call will be held the same day starting at 10:30 CET, where CEO Nicholas Waters and CFO Viktor Siewertz will present the report. The presentation will be held in Swedish and will be followed by a Q&A session.

For those who wish to participate in the conference call, please dial:

SE + 46 850 558 373 or
UK + 44 333 300 9030

It is also possible to follow and listen to the presentation live on https://tv.streamfabriken.com/irlab-q3-2021

The presentation material will be available in Swedish and published in connection with the conference call on www.irlab.se, where the recorded version of the webcast will be available afterwards.